Calendario de eventos




STAT Event: Bispecifics: the next weapon against cancer

Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs, chats with STAT about the lifesaving potential of bispecific antibodies.

A new type of antibody that can attach to more than one protein target may change the way cancer is treated.

Take a look at some of the entrants in a hot new field.


  • Irene Ghobrial, MD, Lavine Family Chair of Preventative Cancer Therapy, Professor of Medicine, Dana Farber Cancer Institute
  • Jill O’Donnell-Tormey, PhD, CEO and Director of Scientific Affairs, Cancer Research Institute
  • Damian Garde, National Biotech Reporter, STAT (moderator)
  • Tony Polverino, PhD, Executive Vice President, Early Development and Chief Scientific Officer, Zymeworks (sponsor speaker)


Leer más:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.